REGISTERED
on 03 Oct 2023
Last Applicant/ Owned by
21 Business Park Drive, Suite 4
Branford
CT
06405
Serial Number
97236881 filed on 25th Jan 2022
Registration Number
7184229 registered on 03rd Oct 2023
Correspondent Address
Francis J. Duffin
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ABBRATECH
Monoclonal antibodies used in research Color is not claimed as a feature of the mark. ABBRA TECH Monoclonal antibodies for therapeutic use, namely, the treatment of medical conditions The mark consists of the stylized words "ABBRATECH" in which the "T" represents a stylized representation of an antibody.
Classification Information
Class [005]
Pharmaceutical Products
Monoclonal antibodies for therapeutic use, namely, the treatment of medical conditions
First Use Date in General
12th Apr 2023
First Use Date in Commerce
12th Apr 2023
Class [001]
Chemical Products
Monoclonal antibodies used in research
First Use Date in General
12th Apr 2023
First Use Date in Commerce
12th Apr 2023
Specimens
Mark Details
Serial Number
No 97236881
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 205698/US001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
03.23.15 -
Micro-organisms (including sperms)
27.03.02 -
Representations of human beings or parts of human beings forming letters or numerals, including punctuation
Description of Design Search
The mark consists of the stylized words "ABBRATECH" in which the "T" represents a stylized representation of an antibody.
Legal History
| Status Date | Action Taken |
|---|---|
| 03rd Oct 2023 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Oct 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 29th Aug 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 28th Aug 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 11th Aug 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 11th Aug 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| 01st Aug 2023 | TEAS STATEMENT OF USE RECEIVED |
| 01st Aug 2023 | USE AMENDMENT FILED |
| 07th Feb 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 13th Dec 2022 | PUBLISHED FOR OPPOSITION |